News

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.
A comprehensive new review by researchers at the University of Kentucky sheds light on the intricate and damaging ...
More than 35 million adults in the U.S. have chronic kidney disease, and just a fraction of them even know it. And the number ...
Pharma major Lupin Ltd on Thursday said it has  received approval from the US health regulator for its generic version of ...
Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of ...
Lupin receives USFDA approval for its generic version of Tolvaptan tablets, indicated for autosomal dominant polycystic ...
Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.
An act of compassion by a young man has ignited a chain reaction of kindness at Providence Swedish Hospital, resulting in five life-saving kidney transplants.
The drug, a copy of Jynarque, could add up to $200 million in annual revenue by FY26, strengthening Lupin’s foothold in ...
Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for ...
A physical therapist was shocked to learn that for her, some of her crucial organs had an expiration date. With proactive ...
On April 15, the Meyers were featured at an event at Springfield City Hall to bring awareness to the importance of organ and ...